Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 282, Issue 3 45-3, 2002, Pages

  Huang, Frederick S ^a   Kemp, Christopher J ^a   Williams, Jodi L ^a   Erwin, Christopher R ^a   Warner, Brad W ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Enteritis; Fluorouracil; Intestinal mucosa; Transforming growth factor ; Transgenic mouse

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; RECOMBINANT EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG INDUCED DISEASE; GASTROINTESTINAL TRACT; GENE OVEREXPRESSION; GENETIC DISORDER; HISTOPATHOLOGY; INTESTINE INJURY; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; TRANSGENIC MOUSE;

EID: 0036088481     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00166.2001     Document Type: Article

References (40)

1. Neutropenic enteropathy: A 10-year review
2. Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents
3. Bacterial translocation from the gastrointestinal tract
4. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection
5. Bombesin improves survival from methotrexate-induced enterocolitis
6. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis
7. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy
8. Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis
9. Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection
10. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality
11. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial
12. A defective EGF-receptor in waved-2 mice attenuates intestinal adaptation
13. Epidermal growth factor enhances repair of rat intestinal mucosa damaged by oral administration of methotrexate
14. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate
15. Chemotherapy-induced intestinal injury is associated with increased paracellular permeability
16. Neutropenic enterocolitis in children with acute lymphoblastic leukemia
17. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome
18. Epidermal growth factor stimulates the recovery of glucose absorption after small bowel transplantation
19. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers
20. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome
21. Effect of epidermal growth factor on experimental colitis in the rat
22. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase
23. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
24. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation
25. Pectin-supplemented enteral diet reduces the severity of methotrexate induced enterocolitis in rats
26. Additive effects of human recombinant interleukin-11 and granulocyte colony-stimulating factor in experimental gram-negative sepsis
27. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation
28. Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats
29. The role of stem cells in the regeneration of intestinal crypts after cytotoxic exposure
30. Morphometric and proliferative effects of growth hormone on radiation enteritis in the rat
31. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats
32. Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan
33. Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression in burned mice
34. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia
35. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy
36. Glucagon-like peptide 2: A new treatment for chemotherapy-induced enteritis
37. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha
38. Neurotensin reduces microbial translocation and improves intestinal mucosa integrity after abdominal radiation
39. Epidermal growth factor limits structural alterations in gastrointestinal tissues and decreases bacterial translocation in burned mice
40. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats